Is IIB up or down today?
IIB is down 0.73% today, last at 82.97. This stock moved -0.73% versus the prior close.
IIB · IIB
IIB (IIB) is trading at 82.97, down 0.73% on the session. IIB sits at the 50% mark of its 52-week range.
Leading the coverage: “SciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock Titan” (Google News Company, 30d ago). IIB is +1.19% since story.
IIB trades on a trailing P/E of 31.8.
Analyst firms are mostly reiterating — no strong directional shift lately.
IIB is down 0.73% today, last at 82.97. This stock moved -0.73% versus the prior close.
Leading the coverage: “SciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock Titan” (Google News Company, 30d ago). IIB is +1.19% since story. Dominant story: HDFC Bank shares to see 57% upside? Bernstein targets for ICICI, Axis, KMB, SBI, IIB - Business Today (1 source, neutral) RSI unavailable Price sits at 50% of its 52-week range Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Historical price chart unavailable
Live quote in the header is real, but OHLC history could not be loaded from Yahoo Finance or fallback providers. Charts use Yahoo when configured correctly — check server logs for provider errors.
HDFC Bank shares to see 57% upside? Bernstein targets for ICICI, Axis, KMB, SBI, IIB - Business Today
Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma - OncLive
Cereno Scientific activates first study center in the Phase IIb EPIMODE study - Biostock
BioVie stock sinks on Phase IIb Parkinson’s trial data - Yahoo Finance
SciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock Titan